{{Rsnum
|rsid=2548003
|Chromosome=5
|position=28747216
|Orientation=minus
|GMAF=0.3829
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;G)
| geno3=(G;G)
| CEU | 10.8 | 52.3 | 36.9
| HCB | 8.9 | 35.6 | 55.6
| JPT | 9.1 | 38.6 | 52.3
| YRI | 28.6 | 50.8 | 20.6
| ASW | 0.0 | 0.0 | 0.0
| CHB | 8.9 | 35.6 | 55.6
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{GWAS Summary
|SNP=rs2548003
|PubMedID=17903296
|Condition=Hip geometry
|Gene=Intergenic
|Risk Allele=
|pValue=2.00E-007
|OR=NA
|95CI=
|OA=1
}}

{{PharmGKB
|RSID=rs2548003
|Name_s=
|Gene_s=-
|Feature=
|Evidence=PubMed ID:17903296; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=GWAS results: Genome-wide association with bone mass and geometry in the Framingham Heart Study (Initial Sample Size: 1,141 individuals (Framingham); Replication Sample Size: NR). This variant is associated with Hip geometry.
|Drugs=
|Drug Classes=
|Diseases=Obesity
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA162356526
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs2548003
|overall_frequency_n=78
|overall_frequency_d=124
|overall_frequency=0.629032
|n_genomes=44
|n_genomes_annotated=0
|n_haplomes=65
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|in_pharmgkb=Y
|autoscore=2
|webscore=N
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | HumanOmni1Quad}}